The answer to the immediate question of how to manage metabolic control in patients with severe COVID-19 is clearer: as with any critically ill patients the consensus is to use intravenous insulin with continuous glucose monitoring, preferably using a closed-loop device (7, 8). The gene discussed is INS; the disease is COVID-19.